Avalo Therapeutics Inc (AVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -63,500 | -16,073 | -40,053 | 11,870 | -16,472 |
| Depreciation Amortization | 1,843 | 5,440 | 6,717 | 563 | 27 |
| Income taxes - deferred | 197 | 17 | -17 | -833 | N/A |
| Accounts receivable | -678 | 1,658 | -223 | -247 | -133 |
| Accounts payable and accrued liabilities | 99 | 1,019 | 83 | 96 | 332 |
| Other Working Capital | -4,451 | -2,023 | 8,708 | -199 | 14 |
| Other Operating Activity | 25,951 | -9,173 | 21,656 | 1,329 | 1,658 |
| Operating Cash Flow | $-40,539 | $-19,134 | $-3,128 | $12,579 | $-14,573 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -63 | -262 | -564 | -23 | -35 |
| Net Acquisitions | N/A | N/A | 0 | -18,889 | N/A |
| Sale Of Investment | 12,837 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -1,642 | -181 | 1,430 | 0 | 0 |
| Investing Cash Flow | $11,132 | $-443 | $866 | $-18,912 | $-35 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -256 | N/A | -2,374 | -3,314 |
| Common Stock Issued | 40,990 | 10,023 | 1,156 | 1,740 | 2,003 |
| Other Financing Activity | 3,794 | 2,793 | 9,248 | 4,371 | -115 |
| Financing Cash Flow | $44,784 | $12,560 | $10,404 | $3,737 | $-1,426 |
| Beginning Cash Position | 3,729 | 10,747 | 2,606 | 5,202 | 21,162 |
| End Cash Position | 19,106 | 3,729 | 10,747 | 2,606 | 5,128 |
| Net Cash Flow | $15,377 | $-7,018 | $8,141 | $-2,596 | $-16,034 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,539 | -19,134 | -3,128 | 12,579 | -14,573 |
| Capital Expenditure | -63 | -262 | -564 | -23 | -35 |
| Free Cash Flow | -40,602 | -19,396 | -3,693 | 12,556 | -14,608 |